CDXC - ChromaDex Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.3700
-0.0300 (-0.6818%)
As of 9:44AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close4.4000
Open4.4500
Bid4.4500 x 6200
Ask4.4800 x 300
Day's Range4.3100 - 4.4650
52 Week Range2.2500 - 4.8500
Volume29,915
Avg. Volume295,761
Market Cap210.02M
Beta1.48
PE Ratio (TTM)-21.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Chromadex Corp. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube23 days ago

    ETFs with exposure to Chromadex Corp. : September 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Chromadex Corp. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cubelast month

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Chromadex Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Chromadex Corp. – Opexa Therapeutics, Inc., Sangamo Therapeutics, Inc. and Exelixis, Inc. (OPXA-US, SGMO-US and EXEL-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CDXC earnings conference call or presentation 10-Aug-17 8:30pm GMT

    Q2 2017 Chromadex Corp Earnings Call

  • Associated Press2 months ago

    ChromaDex reports 2Q loss

    On a per-share basis, the Irvine, California-based company said it had a loss of 7 cents. Losses, adjusted for non-recurring costs, came to 5 cents per share. The natural products company posted revenue ...

  • Capital Cube3 months ago

    ETFs with exposure to Chromadex Corp. : August 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Chromadex Corp. : July 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Chromadex Corp. : June 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Chromadex Corp. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 15, 2017
    Capital Cube4 months ago

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 15, 2017

    Categories: Yahoo FinanceGet free summary analysis Chromadex Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Chromadex Corp. – Natural Alternatives International, Inc., Albany Molecular Research, Inc., Opexa Therapeutics, Inc., Sangamo Therapeutics, Inc., Spherix Incorporated and Exelixis, Inc. (NAII-US, AMRI-US, OPXA-US, SGMO-US, SPEX-US and EXEL-US) ... Read more (Read more...)

  • Associated Press5 months ago

    ChromaDex reports 1Q loss

    The Irvine, California-based company said it had a loss of 5 cents per share. The natural products company posted revenue of $4.4 million in the period. In the final minutes of trading on Thursday, the ...

  • Capital Cube6 months ago

    ETFs with exposure to Chromadex Corp. : April 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to Chromadex Corp. : March 30, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017
    Capital Cube7 months ago

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017

    Categories: Yahoo Finance Get free summary analysis Chromadex Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Chromadex Corp. – Natural Alternatives International, Inc., Albany Molecular Research, Inc., Sangamo Therapeutics, Inc. and Exelixis, Inc. (NAII-US, AMRI-US, SGMO-US and EXEL-US) that have also reported for this period. ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of CDXC earnings conference call or presentation 17-Mar-17 5:00pm GMT

    Q4 2016 Chromadex Corp Earnings Call

  • Capital Cube9 months ago

    ETFs with exposure to Chromadex Corp. : January 24, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube10 months ago

    ETFs with exposure to Chromadex Corp. : December 13, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube11 months ago

    ETFs with exposure to Chromadex Corp. : November 30, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Chromadex Corp. Here are 5 ETFs with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
    Capital Cube11 months ago

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016

    Categories: Yahoo Finance Get free summary analysis Chromadex Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Chromadex Corp. – Natural Alternatives International, Inc., Albany Molecular Research, Inc., Opexa Therapeutics, Inc., Sangamo BioSciences, Inc., Spherix Incorporated and Exelixis, Inc. (NAII-US, AMRI-US, OPXA-US, SGMO-US, SPEX-US and EXEL-US) ... Read more (Read more...)

  • Thomson Reuters StreetEvents11 months ago

    Edited Transcript of CDXC earnings conference call or presentation 10-Nov-16 9:30pm GMT

    Q3 2016 Chromadex Corp Earnings Call